ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

IXHL Incannex Healthcare Ltd

2.55
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:35:59
15분 지연
기업명 주식 심볼 시장 주식 타입
Incannex Healthcare Ltd IXHL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.55 20:35:59
개장가 저가 고가 종가 전일 종가
2.55
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
16/04/202421:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/02/202421:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
16/02/202422:00EDGAR2Form 8-K - Current report
16/02/202421:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/02/202420:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/02/202421:30EDGAR2Form 8-K - Current report
01/02/202421:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
25/01/202406:30EDGAR2Form 8-K - Current report
25/01/202406:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
18/01/202423:08EDGAR2Form 8-K - Current report
18/01/202422:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/01/202421:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/01/202420:05EDGAR2Form 8-K - Current report
22/12/202320:07EDGAR2Form 8-K - Current report
22/12/202310:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202310:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202306:05GLOBEClarion Clinics Receives Ethics Board Endorsement for the..
21/12/202307:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202321:30GLOBEIncannex Update on IHL-42X Drug Candidate in Phase 2/3..
30/11/202303:40GLOBEIncannex Healthcare Announces Completion of..
16/11/202323:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202322:30GLOBEFederal Court of Australia Approves Incannex’s..
08/11/202320:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202319:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/09/202320:30GLOBEIncannex Announces Participation at the H.C. Wainwright 25th..
08/09/202319:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/09/202321:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/08/202320:30GLOBEIncannex to Prepare FDA IND Application for..
22/08/202320:30GLOBEReview of IND Application for IHL-42X by US FDA has been..
08/08/202321:00GLOBEClarion Clinics Begins Accepting Registrations for..
08/08/202319:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/07/202320:30GLOBEIncannex Healthcare June 2023 Quarterly Activities Report..
26/07/202320:30GLOBEIncannex Completes Positive Pre-IND Meeting with US FDA on..
21/07/202322:09GLOBEIncannex Submits IND Application to the US FDA for IHL-42X..
18/07/202320:40GLOBEIncannex engages Fortrea to Manage its FDA IND Opening Phase..
13/07/202321:00GLOBEIncannex Receives HREC Approval for Phase 2 Clinical Trial..
13/07/202319:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/07/202321:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/07/202320:30GLOBEIncannex Announces Intention to Redomicile to United States,..
06/07/202321:42GLOBEIncannex Receives Ethics Approval for..
23/06/202321:00GLOBEIncannex Announces Participation at the H.C. Wainwright 4th..
16/06/202321:00GLOBEIncannex Appoints Principal Investigators for IHL-42X Phase..
30/05/202321:00GLOBEWorld Renowned International Psychedelics Experts Join..
16/05/202320:50GLOBEIncannex Company Presentation – Presentation of Psychennex,..
05/05/202320:30GLOBEIncannex enters a lease for first psychedelic-assisted..

최근 히스토리

Delayed Upgrade Clock